China Feihe

ECM Weekly (3 Nov 2019) - Alibaba, China Feihe, Cal-Comp Tech, Shanghai Kindly, SinoMab, Sinic

380 Views03 Nov 2019 08:21

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

IPO sentiment across Asia is still looking up with the China ADR listings taking the lead this week with a handful of filing. Canaan, Phoenix Tree, I-Mab Bioscience, Lizhi FM, Meili Auto, and Ehang have filed their prospectuses with the SEC and should be listing in the coming weeks. We are also hearing that uCommune, a co-working space operator in China, has filed confidentially.

Back in Hong Kong, Alibaba Group Holding (BABA US) is said to likely file after its 11.11 online retail day and it is looking to list in Hong Kong before the end of the year. This is probably on the back of continuous outperformance of Hong Kong IPOs regardless of deal size as seen from ESR and CMGE debut performance. Other ongoing IPO bookbuild in Hong Kong are Sinic Holdings, SinoMab, and China Feihe while Changsha Broad Homes and Shanghai Kindly are listing on the 6th and 8th of November respectively.

In South-East Asia, ECM activity has been encouraging too. Cal-Comp Tech is looking to open books on Monday while Siam Cement has gotten board approval to spin of Siam Packaging which could be a US$1bn IPO. PTT Oil and Retail is also planning to file its draft prospectus for an IPO of up to US$2bn towards the end of the year.

Accuracy Rate:

Our overall accuracy rate is 72.7% for IPOs and 64.9% for Placements

(Performance measurement criteria is explained at the end of the note)

New IPO filings this week

  • Canaan (~US$400m, the U.S.)
  • Phoenix Tree (~US$300m, the U.S.)
  • I-Mab Bioscience (~US$200m, the U.S.)
  • Lizhi FM (~US$100m, the U.S.)
  • Meili Auto Holdings (~US$100m, the U.S.)
  • Ehang (~US$100m, the U.S.)
  • Central China New Life (~US$100m, Hong Kong)

Below is a snippet of our IPO tool showing upcoming events for the next week. The IPO tool is designed to provide readers with timely information on all IPO related events (Book open/closing, listing, initiation, lock-up expiry, etc) for all the deals that we have worked on. You can access the tool here or through the tools menu.

News on Upcoming IPOs

Analysis on Upcoming IPOs

Hong Kong

Alibaba IPO/Secondary Listing - The Real IPO Only Begins on the 11th Day Post Listing


Alphamab (康宁杰瑞) IPO: Strong R&D Capability and Innovative Platforms

AscentageAscentage Pharma (亚盛医药) IPO: Too Early for an IPO

Ascentage Pharma (亚盛医药) IPO: Updates and Thoughts on HQP1351 (3rd Gen Bcr-Abl TKI)


Ascentage Pharma (亚盛医药) IPO: Some Issues with Banker Forecasts

Ant FinancialAnt Financial IPO Early Thought: Understand Fintech Empire, Growth & Risk Factors

ByteDance (字节跳动) IPO: How Jinri Toutiao Paves The Way for a Bigger Empire (Part 1)


ByteDance (字节跳动) Pre-IPO: Why Facebook Should Worry About TikTok


ByteDance (字节跳动) IPO: Tiktok the No.1 Short Video App for a Good Reason (Part 2)


ByteDance (字节跳动) Pre-IPO: How Has It Done in 1H?


ByteDance: The Unlisted Company’s Video Apps Leading the Market and Threatening Internet Giants


ByteDance (字节跳动) Pre-IPO: Why Facebook Should Worry About TikTok


Clarity Medical (清晰医疗) IPO: Proxy to HK SMILE Surgery Demand


Helenbergh (海伦堡) Early Thoughts - The Usual Red Flag - Related Party Transactions

Home Credit

Home Credit Pre-IPO (Part I) - The Positives - Lots to Like

Home Credit

Home Credit Pre-IPO (Part II) - The Negatives - A Lot More to Dislike

Home Credit

Home Credit Pre-IPO - Bigger but Not Necessarily Better than Peers

Home Credit

Home Credit Pre-IPO - Thoughts on Valuation and the Curious Case of Expanding Equity Base


Huali University (华立大学) IPO Early Thoughts - Risks Abound

Hut Chi-Med

Hutchison-China Med (和黄医药) H-Share Listing: MNC Partnerships Endorsed Its R&D Capabilities


InnoCare (诺诚健华) Pre-IPO: A Decent Team but Short of Clinical Stage Candidates


Jiumaojiu (九毛九) Pre-IPO Early Thoughts - New Brand Driving Growth

MegviiMegvii (旷视) Pre-IPO - Remarkable Growth (Part 1)
MegviiMegvii (旷视) Pre-IPO - A Bet on the Future - Segments, Revenue Drivers and Growth Potential
MegviiMegvii (旷视) Pre-IPO - The Real Race Is in Research - Founders' Profile and Talent
MegviiMegvii (旷视) Pre-IPO - Competitive Landscape and Peer Analysis
MicuRxMicuRx Pharma (盟科医药) IPO: Betting on Single Drug in the Not so Attractive Antibiotic Segment
PharmaronPharmaron (康龙化成) A+H Listing: A Leading Drug Discovery Company
Poly PrpPoly Property Development (保利物业发展) IPO Early Thoughts - Well-Rounded Company

Renrui Human Resources (人瑞人才) Pre-IPO Review - Riding on China's Unicorns


SinoMab (中国抗体): Pipeline Concentrated on Autoimmune Therapy


Smoore Tech (麦克韦尔) IPO: Hidden E-Cigarette Player Behind the FEELM Technology


Smoore Tech (麦克韦尔) Pre-IPO: 6Y and 1H2019 Financials Show Technology Driven Growth

TaslyTasly Biopharm (天士力生物) IPO: Visible Growth from Approved Drug but Lacks Blockbusters
TOT BioTOT Biopharm (东曜药业) IPO: An Unimpressive Pipeline
TOT BioTOT Biopharm (东曜药业) IPO: Valuation of Core Product TAB008, a Bevacizumab Biosimilar
VenusVenus Medtech (启明医疗) IPO: Has the Elements for a Hot Healthcare Deal
VenusVenus Medtech (启明医疗) IPO: Technical Comparison of VenusA-Valve and Peers
ASKASK Investment Managers Pre-IPO - Riding on a Wave of Wealth
Aakash EduAakash Education Pre-IPO - Fast Growth in an Attractive Sector
Anmol IndAnmol Industries Pre-IPO Quick Take - No Growth, Generous Payments to Founders
Bharat Hotels

Bharat Hotels Pre-IPO - Catching up with Peers

Bajaj En

Bajaj Energy Pre-IPO - Supposed to Deliver Steady Performance if Only Its Sole Client Would Let It

CMS InfoCMS Info Systems Pre-IPO - When a PE Sells to Another PE... Only One Gets the Timing Right
Crystal CropCrystal Crop Protection Pre-IPO - DRHP Raises More Questions than in Answers
Flemingo Flemingo Travel Retail Pre-IPO - Its a Different Business in Every Country
Emami CemEmami Cement Pre-IPO - Still in Ramp Up Phase but Emami Shares Pledge Might Lead to an Early IPO
NSENSE IPO Preview- Not Only Fast..its Risky and Expensive
NSENational Stock Exchange Pre-IPO Review - Bigger, Better, Stronger but a Little Too Fast for Some
MazagonMazagon Dock IPO Preview: A Monopoly Submarine Yard in India with Captive Navy Spending
Mrs. BectorMrs. Bectors Food Specialities Pre-IPO Quick Take - Sales for Its Main Segment Have Been Sta


Lodha Developers Pre-IPO - Second Time Lucky but Not Really that Much Affordable
LodhaLodha Developers IPO: Presence in Affordable Segment Saves Lodha the Blushes in a Sluggish Mkt
Penna CemPenna Cement - Aggressive Expansion Plans Even Though Past Performance Has Been Tepid
PNB MetPNB Metlife Pre-IPO Quick Take - Doesn't Stack up Well Versus Its Larger Peers
Samhi HotelsSamhi Hotels Pre-IPO - Assets and Borrowings Are Growing, but Earnings Haven’t Kept Pace
UjjivanUjjivan Small Finance Bank Pre-IPO - Shouldn't Be Forced to List
QSRQSR Brands Pre-IPO - As Healthy as Fast Food
The U.S
36Kr36Kr (36氪) IPO: A Specialized Media Company Struggling to Monetize
CloudMindsCloudMinds Inc Early Thoughts - Still Nascent
FangDDFangDD (房多多) IPO: Reminiscence of SFUN?
HuizeHuize (慧择) Pre-IPO - Insurance Agency Masquerading as a Platform Business
MetenMeten International Edu (美联国际教育) Early Thoughts - Unclear Strategies
Q&KQ&K Intl (青客) IPO: Yet Another WeWork Model that Will Not Work
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

Already have an account? Sign In Now
(Paid Plans Only)